Broekmans Frank J, Visser Jenny A, Laven Joop S E, Broer Simone L, Themmen Axel P N, Fauser Bart C
Department for Reproductive Medicine and Gynecology, University Medical Center, PO Box 85500, 3508 6A, Utrecht, The Netherlands.
Trends Endocrinol Metab. 2008 Nov;19(9):340-7. doi: 10.1016/j.tem.2008.08.002. Epub 2008 Sep 18.
Anti-Müllerian hormone (AMH) has important roles in postnatal ovarian function. Produced by ovarian granulosa cells, AMH is involved in initial follicle development. In fact, serum AMH level correlates with ovarian follicle number. In patients with polycystic ovary syndrome (PCOS), AMH levels are elevated, which indicates its potential relevance in PCOS diagnosis and management. AMH represents a useful clinical marker for the assessment of ovarian reserve in cases of subfertility caused by advanced age in women. A potential role for AMH in dominant follicle selection has also been suggested. Future challenges comprise the availability of a well-standardized assay and the development of AMH agonists and antagonists as possible tools to manipulate ovarian function for contraception or ovarian longevity.
抗苗勒管激素(AMH)在产后卵巢功能中发挥着重要作用。AMH由卵巢颗粒细胞产生,参与初始卵泡发育。实际上,血清AMH水平与卵巢卵泡数量相关。在多囊卵巢综合征(PCOS)患者中,AMH水平升高,这表明其在PCOS诊断和管理中的潜在相关性。对于因女性年龄增长导致的生育力低下病例,AMH是评估卵巢储备的有用临床标志物。也有人提出AMH在优势卵泡选择中可能发挥作用。未来的挑战包括提供标准化良好的检测方法,以及开发AMH激动剂和拮抗剂,作为可能用于控制卵巢功能以实现避孕或延长卵巢寿命的工具。